Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides - PubMed (original) (raw)

Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides

C F Perno et al. J Exp Med. 1988.

Abstract

Because of the probable role of HIV-infected monocyte/macrophages in the pathogenesis and progression of AIDS, it is essential that antiretroviral therapy address viral replication in cells of this lineage. Several dideoxynucleosides have been shown to have potent in vitro and, in the case of 3'-azido-2',3'-dideoxythymidine (AZT) and 2',3'-dideoxycytidine (ddC), in vivo activity against HIV. However, because these compounds must be phosphorylated (activated) in target cells, and because monocyte/macrophages may have levels of kinases that differ from those in lymphocytes, we investigated the capacity of these drugs to suppress HIV replication in monocyte/macrophages using HIV-1/HTLV-IIIBa-L (a monocytotropic isolate). In the present study, we observed that HTLV-IIIBa-L replication in fresh human peripheral blood monocyte/macrophages was suppressed by each of three dideoxynucleosides: 3'-azido-2',3'-dideoxythymidine (AZT), 2',3'-dideoxycytidine (ddC), and 2',3'-dideoxyadenosine (ddA). Similar results were observed in 5-d-cultured monocyte/macrophages, although higher concentrations of the drugs were required. We then studied the metabolism of AZT and ddC in such cells. The phosphorylation of ddC to a triphosphate moiety was somewhat decreased in monocyte/macrophages as compared with H9 T cells. On the other hand, the phosphorylation of AZT in monocyte/macrophages was markedly decreased to 25% or less of the level in T cells. However, when we examined the level of the normal endogenous 2'-deoxynucleoside triphosphate pools, which compete with 2',3'-dideoxynucleoside triphosphate for viral reverse transcriptase, we found that the level of 2'-deoxycytidine-triphosphate (dCTP) was six- to eightfold reduced, and that of 2'-deoxythymidine-triphosphate (dTTP) was only a small fraction of that found in T cell lines. These results suggest that the ratio of dideoxynucleoside triphosphate to normal deoxynucleoside triphosphate is a crucial factor in determining the antiviral activity of dideoxynucleosides in HIV target cells, and that the lower levels of dTTP may account for the antiretroviral activity of AZT in the face of inefficient phosphorylation of this compound.

PubMed Disclaimer

Similar articles

• Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.
  Perno CF, Cooney DA, Gao WY, Hao Z, Johns DG, Foli A, Hartman NR, Caliò R, Broder S, Yarchoan R. Perno CF, et al. Blood. 1992 Aug 15;80(4):995-1003. Blood. 1992. PMID: 1379854
• Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
  Richman DD, Kornbluth RS, Carson DA. Richman DD, et al. J Exp Med. 1987 Oct 1;166(4):1144-9. doi: 10.1084/jem.166.4.1144. J Exp Med. 1987. PMID: 2821152 Free PMC article.
• Initial clinical experience with dideoxynucleosides as single agents and in combination therapy.
  Yarchoan R, Pluda JM, Perno CF, Mitsuya H, Thomas RV, Wyvill KM, Broder S. Yarchoan R, et al. Ann N Y Acad Sci. 1990;616:328-43. doi: 10.1111/j.1749-6632.1990.tb17853.x. Ann N Y Acad Sci. 1990. PMID: 2078027 Review.
• Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
  Balzarini J. Balzarini J. Pharm World Sci. 1994 Apr 15;16(2):113-26. doi: 10.1007/BF01880662. Pharm World Sci. 1994. PMID: 8032337 Review.

Cited by

• Activities of masked 2',3'-dideoxynucleoside monophosphate derivatives against human immunodeficiency virus in resting macrophages.
  Aquaro S, Wedgwood O, Yarnold C, Cahard D, Pathinara R, McGuigan C, Calio' R, de Clercq E, Balzarini J, Perno CF. Aquaro S, et al. Antimicrob Agents Chemother. 2000 Jan;44(1):173-7. doi: 10.1128/AAC.44.1.173-177.2000. Antimicrob Agents Chemother. 2000. PMID: 10602742 Free PMC article.
• Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum.
  Ellis GM, Huang S, Hitti J, Frenkel LM; P1022 Study Team. Ellis GM, et al. J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):241-7. doi: 10.1097/QAI.0b013e31822b4edc. J Acquir Immune Defic Syndr. 2011. PMID: 21765365 Free PMC article.
• Induction of beta interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication.
  Gessani S, Puddu P, Varano B, Borghi P, Conti L, Fantuzzi L, Belardelli F. Gessani S, et al. J Virol. 1994 Mar;68(3):1983-6. doi: 10.1128/JVI.68.3.1983-1986.1994. J Virol. 1994. PMID: 8107259 Free PMC article.
• Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
  Magnani M, Casabianca A, Fraternale A, Brandi G, Gessani S, Williams R, Giovine M, Damonte G, De Flora A, Benatti U. Magnani M, et al. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4403-8. doi: 10.1073/pnas.93.9.4403. Proc Natl Acad Sci U S A. 1996. PMID: 8633079 Free PMC article.

References

1. 1. Biochem Pharmacol. 1987 Jun 1;36(11):1765-8 - PubMed
2. 1. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2469-73 - PubMed
3. 1. N Engl J Med. 1987 Jul 30;317(5):278-86 - PubMed
4. 1. Antimicrob Agents Chemother. 1987 Apr;31(4):600-4 - PubMed
5. 1. Antiviral Res. 1987 Mar;7(3):139-49 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database